Testing effectiveness (Phase 2)Looking for participantsNCT07139977What this trial is testingStudy of EV for Recurrent Endometrial CarcinomaWho this might be right forEndometrial Cancer William Bradley 12
Testing effectiveness (Phase 2)Looking for participantsNCT04486352What this trial is testingTargeted Agents for Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial Cancer Alliance Foundation Trials, LLC. 148
Testing effectiveness (Phase 2)UnknownNCT00006903What this trial is testingFulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial CancerWho this might be right forRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Uterine Corpus Cancer AJCC v7 Gynecologic Oncology Group 67
Testing effectiveness (Phase 2)Study completedNCT00095979What this trial is testingIxabepilone in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaRecurrent Endometrial CarcinomaStage IV Endometrial Carcinoma National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Study completedNCT00005031What this trial is testingIrofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912572What this trial is testingAvelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial CancerWho this might be right forMetastatic Endometrial Cancer Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Study completedNCT02549989What this trial is testingStudy of LY3023414 for the Treatment of Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial CancerRecurrent Endometrial Cancer Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01210222What this trial is testingTrebananib in Treating Patients With Persistent or Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT05156268What this trial is testingPembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial CarcinosarcomaWho this might be right forEndometrial Carcinosarcoma Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04106414What this trial is testingStudy of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to TreatmentWho this might be right forEndometrial AdenocarcinomaEndometrial Carcinosarcoma Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02228681What this trial is testingEverolimus and Letrozole or Hormonal Therapy to Treat Endometrial CancerWho this might be right forAdvanced, Persistent, or Recurrent Endometrial Cancer GOG Foundation 74
Testing effectiveness (Phase 2)Study completedNCT01132820What this trial is testingCediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT00023894What this trial is testingFlavopiridol in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group
Not applicableStudy completedNCT02093546What this trial is testingBiospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290Who this might be right forRecurrent Endometrial Carcinoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00888173What this trial is testingBrivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more Gynecologic Oncology Group 45
Testing effectiveness (Phase 2)Looking for participantsNCT06677190What this trial is testingBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginWho this might be right forOvarian CancerOvarian CarcinomaEndometrial Cancer+5 more Dana-Farber Cancer Institute 32
Early research (Phase 1)Study completedNCT01935973What this trial is testingTrametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+3 more National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)WithdrawnNCT00003821What this trial is testingAminopterin in Treating Patients With Recurrent or Refractory Endometrial CancerWho this might be right forEndometrial Cancer Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Active Not RecruitingNCT03526432What this trial is testingPhase II Study of Atezolizumab + Bevacizumab in Endometrial CancerWho this might be right forEndometrial Cancer University of Oklahoma 110